COMMUNIQUÉS West-GlobeNewswire

Canada’s Stem Cell Network Welcomes Renewed Federal Commitment for Stem Cell & Regenerative Medicine Research
20/03/2019
OTTAWA, March 20, 2019 (GLOBE NEWSWIRE) -- Through Budget 2019, the Government of Canada has signalled its continued confidence in Canadian stem cell and regenerative medicine research with a multi-year investment of $ [...]
Le Réseau de cellules souches du Canada se réjouit de l’engagement renouvelé du gouvernement fédéral envers la recherche sur les cellules souches et en médecine régénérative
20/03/2019
OTTAWA, 20 mars 2019 (GLOBE NEWSWIRE) -- Dans son budget de 2019, le gouvernement du Canada a confirmé sa confiance continue dans la recherche canadienne sur les cellules souches et en médecine régénérative avec un [...]
Humana Selects The Inovalon ONE® Platform
20/03/2019
Leading National Health Plan to Implement Inovalon’s Data-Driven Solution Across 17 States to Empower Enhanced Outcomes And Economics BOWIE, Md., March 20, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]
Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer
20/03/2019
Appointment Adds Extensive Strategic Expertise in the Latin American and International Cannabis Industries and Related Capital Markets TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) ( [...]
BeyondSpring to Present Clinical Trial Data on Lead Asset, Plinabulin, at 2019 St. Gallen International Breast Cancer Conference
20/03/2019
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company will present [...]
Zealand Pharma increases its share capital as a consequence of a new issue of shares
20/03/2019
Company announcement – No. 7/2019 Zealand Pharma increases its share capital as a consequence of a new issue of shares Zealand Pharma A/S' board of directors has exercised an authorization granted by its extraordinary [...]
European Medicines Agengy Issues Certificates for Trogarzo® Manufacturing Sites
20/03/2019
MONTREAL, March 20, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Wuxi Biologics facilities set to manufacture Trogarzo ® for the European market have [...]
L’agence européenne des médicaments émet les certificats pour les sites de fabrication de Trogarzo(MD)
20/03/2019
MONTRÉAL, 20 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que les installations de Wuxi Biologics, prévues pour la fabrication du Trogarzo MD destiné au [...]
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
20/03/2019
Company announcement – No. 06 / 2019 Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases Collaboration furthers Alexion’s complement leadership [...]
Interview with Gabriella's Kitchen CEO Margot Micallef -- CFN Media
20/03/2019
SEATTLE, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
CB2 Insights Signs Agreement to Acquire Medical Cannabis Clinic Group in Colorado and Arizona
20/03/2019
First acquisition post-RTO to consolidate the US medical cannabis clinical market; increases revenues, patient count and jurisdictions served TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “ [...]
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results
20/03/2019
BERKELEY HEIGHTS, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology
20/03/2019
RTI continues to advance its growing body of clinical evidence for the Fortilink Interbody Fusion Device with TETRAfuse 3D Technology DEERFIELD, Ill., March 20, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. ( [...]
Emerald Health Therapeutics Applauds Government of Canada for Proposing Amendment to Cannabis Excise Tax in Federal Budget
20/03/2019
VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the [...]
Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200
20/03/2019
New Intellectual Property Covers Composition of Matter and Manufacturing Method out to Mid-2030s CRANBURY, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the United [...]
Maryland GI Raises Colorectal Cancer Awareness with Radio Personality Russ Parr
20/03/2019
Colorectal cancer is one of the most prevalent and deadly cancers in the U.S. Capital Digestive Care is spreading the word during Colorectal Cancer Awareness Month that this type of cancer can be prevented ROCKVILLE, Md [...]
New AroCell patent granted by the EPO
20/03/2019
AroCell announced today that the patent nr. 3083698 and titled” Monoclonal Anti-TK1 Antibodies” is granted by European Patent Office and will be published on April 10, 2019 The patent is referring to AroCell’s [...]
CORRECTED VERSION of March 20, 2019 Press Release: New scientific publication from AroCell on TK 210 ELISA in prostate cancer
20/03/2019
In the corrected version of the press release we have added a link to the article. The aim of the study was to investigate the diagnostic value of the AroCell TK 210 ELISA together with free PSA, pro PSA and PHI in [...]
Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019
20/03/2019
Heidelberg, Germany, March 20, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced that it will host a [...]

Pages